HRT Financial’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-84,970
| Closed | -$5.8M | – | 2516 |
|
|
2025
Q1 | $5.8M | Sell |
84,970
-201,552
| -70% | -$13.8M | 0.04% | 319 |
|
|
2024
Q4 | $22.3M | Buy |
+286,522
| New | +$22.3M | 0.12% | 73 |
|
|
2023
Q4 | – | Sell |
-50,470
| Closed | -$4.71M | – | 2284 |
|
|
2023
Q3 | $4.71M | Buy |
+50,470
| New | +$4.71M | 0.05% | 295 |
|
|
2023
Q2 | – | Sell |
-72,056
| Closed | -$8.37M | – | 2440 |
|
|
2023
Q1 | $8.37M | Sell |
72,056
-96,649
| -57% | -$11.2M | 0.1% | 166 |
|
|
2022
Q4 | $19.1M | Buy |
168,705
+143,519
| +570% | +$16.3M | 0.27% | 61 |
|
|
2022
Q3 | $2.03M | Sell |
25,186
-20,128
| -44% | -$1.62M | 0.02% | 574 |
|
|
2022
Q2 | $3.38M | Buy |
+45,314
| New | +$3.38M | 0.04% | 360 |
|
|
2022
Q1 | – | Sell |
-6,296
| Closed | -$845K | – | 2980 |
|
|
2021
Q4 | $845K | Buy |
+6,296
| New | +$845K | ﹤0.01% | 1127 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 3123 |
|
|
2020
Q3 | – | Sell |
-167,816
| Closed | -$17M | – | 1899 |
|
|
2020
Q2 | $17M | Buy |
+167,816
| New | +$17M | 0.51% | 32 |
|
|
2019
Q4 | – | Sell |
-20,708
| Closed | -$772K | – | 1205 |
|
|
2019
Q3 | $772K | Buy |
+20,708
| New | +$772K | 0.04% | 394 |
|
|
2019
Q2 | – | Sell |
-10,816
| Closed | -$322K | – | 765 |
|
|
2019
Q1 | $322K | Buy |
+10,816
| New | +$322K | 0.05% | 248 |
|
|
2018
Q4 | – | Sell |
-8,972
| Closed | -$320K | – | 600 |
|
|
2018
Q3 | $320K | Buy |
+8,972
| New | +$320K | 0.05% | 201 |
|